SOAT1 and neoplasm: Our examination of published patient data revealed that enhanced inflammatory signaling was characteristic of a CAR-T resistant microenvironment - patient tumor samples with elevated JAK/STAT/MHC-I expression prior to CAR-T treatment were associated with poor outcomes.